Evidence map›Paper›PMID 39277179›Full record

ArticleBMJ open ophthalmology2024

Recurrent ocular toxoplasmosis is associated with interferon-gamma deficiency possibly due to genetic origin.

Nina Maria Hautala, Maija Joensuu, Teija Paakkola, Virpi Glumoff, Kaisa Kettunen, Janna Saarela, Mira Siiskonen, Zhi Chen, Katri Pylkäs, Timo Hautala

Abstract read
In one paragraph

Article in BMJ open ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nina Maria HautalaResearch Unit of Clinical Medicine, Department of Ophthalmology, University of Oulu, Oulu, Finland.ORCID 0000-0001-5454-5602
Maija JoensuuNorthern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.
Teija PaakkolaNorthern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.
Virpi GlumoffResearch Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland.ORCID 0000-0003-3461-6471
Kaisa KettunenHUS Diagnostic Center, Division of Genetics and Clinical Pharmacology, Laboratory of Genetics, HUS Helsinki University Hospital, Helsinki, Finland.
Janna SaarelaHiLIFE, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Mira SiiskonenDepartment of Ophthalmology, Oulu University Hospital, Oulu, Finland.
Zhi ChenFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Katri PylkäsNorthern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland.
Timo HautalaResearch Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland timo.hautala@oulu.fi.ORCID 0000-0001-7889-1614

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOcular toxoplasmosis (OT) can cause posterior uveitis; causes of recurrent OT are not well understood. We explored clinical, immunological and genetic properties associated with recurrent OT. METHODS AND ANALYSIS: A recurrent OT patient population (n=9) was identified. Clinical history, ophthalmological findings and immunological properties were assessed. B and T cell immunophenotyping including interferon-gamma (IFN-γ) responses were analysed. An analysis of 592 immunodeficiency genes was performed.

resultsThe patients experienced 2-7 OT episodes (average 3.7). The first episode occurred at an average of 23.8 (SD 10.1) years of age. All patients had anterior uveitis, vitritis and various fundus lesions of OT. The patients had lymphocyte maturation abnormalities; the proportion of naive CD4

conclusionOur recurrent OT cases had deviations in lymphocyte maturation and IFN-γ responses possibly caused by genetic reasons. However, limitations of our study include failure to identify uniform genetic mechanisms. In addition, we cannot rule out the possibility that the immunological abnormalities can be triggered by chronic toxoplasmosis. Despite the limitations, our findings contribute to the understanding of ocular immunity and development of recurrent OT.

Indexed as

Interferon-gammaRecurrenceToxoplasmosis, OcularAdolescentAdultChildFemaleHumansImmunophenotypingMaleMiddle AgedYoung AdultIFNG protein, humanInterferon-gammaGeneticsImmunologyInfectionInflammation

Identifiers

PMID39277179
PMCPMC11404243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.